Search - tctmd.com

Displaying 201 - 220 of 1178

Sort: Relevancy | Date

AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes

News Daily News

AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes

April 26, 2024

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

News Daily News

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

April 22, 2024

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

News Daily News

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

April 19, 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

April 10, 2024

Some Degree of Hemolysis Seen in Nearly All Pulsed-Field Ablation Cases

News Conference News EHRA 2024

Some Degree of Hemolysis Seen in Nearly All Pulsed-Field Ablation Cases

April 09, 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

April 07, 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

April 06, 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

April 06, 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

FDA Approves TriClip TEER Device for Tricuspid Repair

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

April 02, 2024

April 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

April 01, 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

News Daily News

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

March 18, 2024

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

March 11, 2024

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

March 07, 2024

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Presentation THT 2024

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Presenter: Liviu Klein

March 05, 2024

Debating the Role of T-TEER in the Sickest Patients

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.